ANAB vs VTR · rev $234.6M vs P/E 149, rev $1.73B
AnaptysBio Inc (ANAB) versus Ventas Inc (VTR) — a side-by-side from cached financials, not a winner call.
AnaptysBio Inc (ANAB) is a biotechnology company listed on NASDAQ.
Ventas Inc (VTR) is a reit - healthcare facilities company listed on NYSE.
Latest reported ANAB revenue for 2025-12-31 was $234.6M. Net income was -$13.2M. Revenue was up 157.0% from 2024-12-31 to 2025-12-31. ANAB currently screens at market cap $1.62B.
Latest reported VTR revenue for 2026-06-30 was $1.73B. Net income was $72.2M. Revenue was up 4.4% from 2026-03-31 to 2026-06-30. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
ANAB currently screens at market cap $1.62B. VTR currently screens at market cap $39.94B and trailing P/E 149.4.
Not investment advice. Open the ANAB and VTR stock pages for the full models.
Not investment advice.